Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain

Author： Tanasescu Radu   Constantinescu Cris S  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.9, 2013-09, pp. : 1219-1228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis

By Wiese Michael D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1025-1035

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis

By Tanasescu Radu   Constantinescu Cris S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 621-630

Informa Healthcare

Access to resources Recommend Favorite

Drugs Treatment of Pain in Multiple Sclerosis

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of mitoxantrone for the treatment of multiple sclerosis

By Jain K.K.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 1139-1149

Informa Healthcare

Access to resources Recommend Favorite

Willingness to Pay for a Treatment for Pain in Multiple Sclerosis

By Iskedjian Michael   Desjardins Olivier  

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 149-158

Adis International

Access to resources Recommend Favorite